Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $12.87B | $830.81M | $7.85M | $54.20M | $0.53 | 16.02% | 19.35% | -57.94% | -8.80% | |||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $32.46B | $4.80B | $1.18B | $807.99M | $6.10 | 95.14% | 47.52% | N/A | N/A | |||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $6.30B | $840.85M | $119.96M | $80.66M | $1.07 | 58.85% | 155.62% | 1,683.33% | N/A | |||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $3.33B | $463.98M | $45.39M | $28.52M | $0.21 | 76.11% | N/A | N/A | N/A | |||
| ADMA | ADMA BIOLOGICS INC | $2.25B | $512.28M | $232.99M | $168.96M | $0.72 | 8.04% | 54.54% | -18.18% | N/A | |||
| HALO | HALOZYME THERAPEUTICS INC | $12.21B | $1.66B | $718.44M | $413.60M | $3.56 | 41.15% | 32.17% | -20.54% | 16.63% | |||
| VCEL | VERICEL CORP | $2.23B | $306.30M | $44.05M | $24.22M | $0.48 | 22.95% | 15.11% | 242.86% | 19.14% | |||
| KRYS | KRYSTAL BIOTECH INC | $10.16B | $440.48M | $233.29M | $241.47M | $8.27 | 22.63% | N/A | 61.84% | N/A | |||
| RPRX | ROYALTY PHARMA PLC | $35.49B | $2.54B | $1.18B | $815.00M | $1.88 | 10.01% | 2.53% | -18.97% | -5.47% | |||
| TGTX | TG THERAPEUTICS INC | $7.91B | $799.54M | $139.21M | $441.49M | $3.08 | 76.08% | 219.17% | 651.22% | N/A | |||
| ZVRA | ZEVRA THERAPEUTICS INC | $720.33M | $136.07M | $77.33M | $58.26M | $0.95 | 119.40% | 36.81% | N/A | N/A | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $13.42B | $3.41B | $385.69M | $72.97M | $0.38 | 11.20% | 12.19% | -88.95% | -39.24% | |||
| NAGE | NIAGEN BIOSCIENCE INC | $250.83M | $129.08M | $18.69M | $15.99M | $0.20 | 10.99% | 15.79% | -13.04% | N/A | |||
| LGND | LIGAND PHARMACEUTICALS INC | $5.80B | $290.54M | $278.98M | $197.22M | $10.07 | 54.89% | 4.89% | N/A | 28.45% | |||
| VRTX | VERTEX PHARMACEUTICALS INC | $139.93B | $12.59B | $5.50B | $4.41B | $17.33 | 10.23% | 13.50% | 22.73% | 17.68% | |||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $16.37B | $4.60B | $1.62B | $940.76M | $15.26 | 12.59% | 11.87% | N/A | 68.91% | |||
| SPRO | SPERO THERAPEUTICS INC | $71.63M | $47.00M | $7.64M | $7.38M | $0.14 | -3.25% | 20.69% | N/A | N/A | |||
| TECH | BIO-TECHNE CORP | $11.35B | $1.21B | $255.98M | $109.56M | $0.71 | 0.17% | 7.39% | -14.46% | -9.99% | |||
| MDXG | MIMEDX GROUP INC | $648.63M | $355.17M | $22.81M | $6.24M | $0.04 | -2.36% | 6.36% | -81.82% | N/A | |||
| EXEL | EXELIXIS INC | $13.48B | $2.44B | $1.09B | $860.62M | $3.29 | 9.23% | 16.06% | 53.02% | 60.39% | |||
| UTHR | UNITED THERAPEUTICS CORP | $22.70B | $3.15B | $1.68B | $1.31B | $30.24 | 2.49% | 14.68% | 9.25% | 23.42% | |||
| REGN | REGENERON PHARMACEUTICALS INC | $86.57B | $15.53B | $5.75B | $4.33B | $41.94 | 9.29% | 4.64% | 0.43% | -6.56% | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.33B | $959.90M | $280.01M | $181.27M | $3.14 | 24.25% | 32.46% | -0.63% | 10.45% | |||
| INCY | INCYTE CORP | $26.04B | $5.82B | $2.07B | $1.61B | $8.12 | 26.93% | 16.42% | 83.71% | 39.45% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.